Skip to content

Drug interactions

Fluticasone + Larotrectinib

Severity: Minor

Fluticasone and Larotrectinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Larotrectinib is a CYP3A4 substrate with weak inhibitory activity and is unlikely to change fluticasone exposure meaningfully. Clinical relevance is doubtful.

What this interaction means in plain words

Fluticasone and Larotrectinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Fluticasone belongs to Respiratory; Larotrectinib belongs to Oncology.

Evidence level: Low

Why it happens

Possible weak CYP3A4 inhibition by larotrectinib; not well established.

What to do

No specific action is required; monitor for signs of corticosteroid excess during long-term combined use.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fluticasone and Larotrectinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Fluticasone with Larotrectinib?

MediHelp rates the interaction as minor. Fluticasone and Larotrectinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Larotrectinib is a CYP3A4 substrate with weak inhibitory activity and is unlikely to change fluticasone exposure meaningfully. Clinical relevance is doubtful.

How serious is the interaction between Fluticasone and Larotrectinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No specific action is required; monitor for signs of corticosteroid excess during long-term combined use.

What other medicines interact with Fluticasone?

MediHelp also lists interactions of Fluticasone with, for example, Atazanavir, Clarithromycin, Cobicistat. The full list is on the Fluticasone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in